John Pattaras MD/FACS
- Department of Urology
Professor
- (404) 778-4898
- Emory University
- My Information
- WCI
-
Emory Urology
5673 Peachtree Dunwood Road, Suite 350A
Overview
Dr. John G. Pattaras joined Emory Urology in 2000. He is the James C. Kennedy Chair of Prostate Surgery, Director of Minimally Invasive Surgery and Associate Professor of Urology at the Emory University School of Medicine, He serves as the Medical Director for Emory Urology and former Chief of Urology at Saint Josephs Hospital.
Dr. Pattaras attended The Johns Hopkins University for his undergraduate education. He received his medical degree and urology residency training at The George Washington University School of Medicine. He attended the National Cancer Institute/National Institutes of Health for a fellowship in Biotechnology focusing on prostate cancer research. After residency, Dr. Pattaras completed an Endourology and Laparoscopy fellowship training at St. Louis University Medical Center. Dr. Pattaras is a diplomate of the American Board of Urology (2002) and a Fellow of the American College of Surgery.
As the Director of Minimally Invasive Surgery, Dr. Pattaras started a laparoscopic and robotic urologic surgery program at Emory University. Over the past 20 years, the program has expanded to become the premier laparoscopic and robotics program in the Atlanta area and expanding across the Southeast and even reaching international patients. The program offers highly specialized minimally invasive surgery that includes robotic prostate surgery, kidney-sparing cancer surgery and complex reconstructive upper urinary surgery. Patients attending Emory Urology for cancer treatment have the unique opportunity to be cured of their disease while at the same time preserve their vital organs, their function and quality of life.
After moving his practice to Emory Saint Joseph's Hospital in 2014 Dr. Pattaras has helped grow the Emory robotics program having performed hundreds of prostate and kidney cancer surgeries. In addition, he helped establish a Multi-Disciplinary Prostate Cancer clinic at ESJH which patients see multiple physicians who can offer different treatment options customized to the patient's needs. He also very involved and specialiizes in high dose radiation (HDR) brachytherapy which involves a minimally invasive way of delivering radiation therapy directly into the prostate to lessen side effects and improve outcomes.
Dr. Pattarass clinical and research interests include minimally invasive cancer, urinary stone surgery, endourology, laparoscopy and robotic surgery. He has lectured both nationally and internationally. He is invited to participate annually in national and international conferences focusing on prostate and kidney cancer. He is closely involved in teaching and mentoring medical students, urology residents, physician assistants and post-graduate fellows. He has authored dozens of book chapters, and scientific journal articles.
In addition to his dedication to his patients, Dr. Pattaras has been involved in humanitarianism outside the U.S. For several years, he volunteered his time to organize and lead a team of Emory medical students to Haiti. The team provided free urologic care including surgical treatment to indigent Haitian patients with urologic conditions and continues on today.
Dr. Pattaras lives near Emory University with his wife Kristy and daughter Anna. He enjoys tennis, motorcycles and mixed martial arts.
Academic Appointment
- Professor, Department of Urology, Emory University School of Medicine
- James C. Kennedy Chair in Prostate Surgery, Winship Cancer Institute of Emory University
Education
Degrees
- BA from Johns Hopkins University, Baltimore
- MD from George Washington University School of Medicine
Research
Focus
- My research focuses on minimally invasive genito-urinary surgery including, but not limited to, robotic/laparoscopic/endourologic reconstructive, oncology and urolithiasis procedures. I have examined and published on laparoscopic suturing techniques, adhesion formation after laparoscopic surgery, morbidity after pediatric laparoscopic surgery, outcomes of extracorporeal shock wave lithotripsy between devices and feasibility of new laparoscopic and robotic procedures.
Publications
-
A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in Drosophila.
Genetics Volume: 226
04/03/2024 Authors: Brockett JS; Manalo T; Zein-Sabatto H; Lee J; Fang J; Chu P; Feng H; Patil D; Davidson P; Ogan K -
Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate Cancer.
Eur Urol Open Sci Volume: 37 Page(s): 80 - 89
03/01/2022 Authors: Fischer-Valuck BW; Baumann BC; Brown SA; Filson CP; Weiss A; Mueller R; Liu Y; Brenneman RJ; Sanda M; Michalski JM -
Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis.
Int J Urol Volume: 27 Page(s): 790 - 797
09/01/2020 Authors: Obeng RC; Arnold RS; Ogan K; Master VA; Pattaras JG; Petros JA; Osunkoya AO -
Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell Carcinoma.
Volume: 141 Page(s): 101 - 107
07/01/2020 Authors: Patil D; Le T-L; Bens KB; Alemozaffar M; Lay A; Pattaras J; Filson CP; Ogan K; Bilen MA; Master VA -
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer.
Brachytherapy Volume: 19 Page(s): 557 - 566
01/01/2020 Authors: Fischer-Valuck BW; Rao YJ; Brenneman RJ; Patel PR; Filson CP; Jani AB; Liu Y; Goyal S; Xu K; Weiss A -
Safety of high dose rate prostate brachytherapy in patients with high baseline international prostate symptom scores.
Volume: 37
03/01/2019 Authors: Morgan T; Rossi PJ; Cutrell P; Zhang C; Press RH; Rahnema S; Sanda MG; Pattaras J; Cimmino CB; Jani AB -
Patient-reported health-related quality of life outcomes after HDR brachytherapy between small (<60cc) and large (60cc) prostate glands.
Brachytherapy Volume: 18 Page(s): 13 - 21
01/01/2019 Authors: Press RH; Morgan TM; Cutrell PK; Zhang C; Chen Z; Rahnema S; Sanda M; Pattaras J; Patel P; Jani AB -
High-dose-rate prostate brachytherapy appears safe in patients with high baseline International Prostate Symptom Scores.
Brachytherapy Volume: 18 Page(s): 793 - 799
01/01/2019 Authors: Morgan TM; Rossi PJ; Cutrell PK; Zhang C; Press RH; Rahnema S; Sanda M; Pattaras J; Cimmino C; Hershatter B -
Brachytherapy for localized prostate cancer in the modern era: a comparison of patient-reported quality of life outcomes among different techniques.
J Contemp Brachytherapy Volume: 10 Page(s): 495 - 502
12/01/2018 Authors: Morgan TM; Press RH; Cutrell PK; Zhang C; Chen Z; Rahnema S; Sanda M; Pattaras J; Patel PR; Jani AB -
Lymphadenectomy for High-Risk Prostate Cancer Patients: What Is Going on in Georgia?
Volume: 227 Page(s): S281 - S282
10/01/2018 Authors: Henry M; Taylor M; Kim F; Pattaras JG; Alemozaffar M; Master V; Filson CP